Gara Jalqabaatti › Dukkana Bladder › Wisconsin

Qorannoo klinikaalii Dukkana Bladder Wisconsin keessatti

Qorannoo 17 Dukkana Bladder f Wisconsin keessatti hirmaatuu jiru.

Magaalota Wisconsin keessatti

Takkalaa qorannoo (Ingiliffa)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
ThedaCare Regional Medical Center - Appleton, Appleton
fi 50 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
fi 5 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06770582

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

UW Health Carbone Cancer Center, Madison

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06760819

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield
Ascension Calumet Hospital-Chilton, Chilton
fi 11 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
Marshfield Medical Center-EC Cancer Center, Eau Claire
fi 25 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ThedaCare Regional Cancer Center, Appleton

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

The Vanguard Study: Testing a New Way to Screen for Cancer

Zablocki Veterans Administration Medical Center, Milwaukee

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06995898

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Froedtert Hospital, Milwaukee

Namoota walitti qabaa jira

Umuriin 65 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07227077

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Langlade Hospital and Cancer Center, Antigo
Cancer Center of Western Wisconsin, New Richmond
Aspirus Cancer Care - James Beck Cancer Center, Rhinelander
fi 3 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07097142

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

University of Wisconsin- Madison, Madison

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Froedtert Hospital / Medical College of Wisconsin, Milwaukee

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT04752722

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, Milwaukee

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Froedtert Hospital/Medical College of Wisconsin, Milwaukee

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT04879329

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

University of Wisconsin-Madison, Madison

Namoota walitti qabaa jira

Umuriin 18 hanga 88 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT06394869

Integrated Cancer Repository for Cancer Research

Bellin Memorial Hospital, Green Bay

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 19 hanga 110 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT02012699

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Medical College of Wisconsin, Milwaukee

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT04075305

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Milwaukee

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.